Weian Zhao is an expert in single-cell analysis, microfluidics, immunotherapeutics, and synthetic biology. He was a tenured professor at UC Irvine and a serial entrepreneur. Notably, he has successfully led immunotherapeutics through FDA IND approval. Zhao has been recognized as one of MIT Technology Review's TR35 innovators and is a recipient of the NIH Director's New Innovator Award, highlighting his contributions to advancing healthcare and biotechnology.